4.7 Article

The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function

Journal

NATURE IMMUNOLOGY
Volume 12, Issue 9, Pages 888-U11

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ni.2068

Keywords

-

Categories

Funding

  1. US National Institutes of Health [K01 AR053573, R01 NS064599]
  2. Arthritis Foundation
  3. Lupus Research Institute
  4. American Lebanese Syrian Associated Charities

Ask authors/readers for more resources

The mechanisms that regulate T cell quiescence are poorly understood. We report that the tumor suppressor Tsc1 established a quiescence program in naive T cells by controlling cell size, cell cycle entry and responses to stimulation of the T cell antigen receptor. Abrogation of quiescence predisposed Tsc1-deficient T cells to apoptosis that resulted in loss of conventional T cells and invariant natural killer T cells. Loss of Tsc1 function dampened in vivo immune responses to bacterial infection. Tsc1-deficient T cells had more activity of the serine-threonine kinase complex mTORC1 but less mTORC2 activity, and activation of mTORC1 was essential for the disruption of immune homeostasis. Therefore, Tsc1-dependent control of mTOR is crucial in actively maintaining the quiescence of naive T cells to facilitate adaptive immune function.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available